Summary.-Extracts of glioblastomas and meningiomas were analysed by quantitative immunoelectrophoresis for the presence of foetal brain antigens and tumourassociated antigens, and levels of 2 normal brain-specific proteins were also determined. The following antibodies were used: monospecific anti-S-100 (glia specific); monospecific anti-GFA (glial fibrillary acidic protein), (astroglia specific); polyspecific anti -foetal brain (12-16th week of gestation); a polyspecific anti-glioblastoma antiserum, absorbed with insolubilized serum, haemolysate and normal brain extract; polyspecific anti-meningioma antiserum, absorbed as for glioblastoma antiserum; monospecific anti-a-foetoprotein; and monospecific anti-ferritin. Using the antibodies raised against the tumours, several antigens not present in foetal or adult normal brain were found in the glioblastomas and the meningiomas. These antigens cross -reacted with antigens present in normal liver and were therefore not tumour-associated. S-100 was found in glioblastomas in approximately one tenth the amount in whole brain homogenate, whereas GFA was found 2-4 times enriched. The 2 proteins were absent in meningiomas. The possible use of the GFA protein as a marker for astroglial neoplasia is discussed.
Summary.-Extracts of glioblastomas and meningiomas were analysed by quantitative immunoelectrophoresis for the presence of foetal brain antigens and tumourassociated antigens, and levels of 2 normal brain-specific proteins were also determined. The following antibodies were used: monospecific anti-S-100 (glia specific); monospecific anti-GFA (glial fibrillary acidic protein), (astroglia specific); polyspecific anti -foetal brain (12-16th week of gestation); a polyspecific anti-glioblastoma antiserum, absorbed with insolubilized serum, haemolysate and normal brain extract; polyspecific anti-meningioma antiserum, absorbed as for glioblastoma antiserum; monospecific anti-a-foetoprotein; and monospecific anti-ferritin. Using the antibodies raised against the tumours, several antigens not present in foetal or adult normal brain were found in the glioblastomas and the meningiomas. These antigens cross -reacted with antigens present in normal liver and were therefore not tumour-associated. S-100 was found in glioblastomas in approximately one tenth the amount in whole brain homogenate, whereas GFA was found 2-4 times enriched. The 2 proteins were absent in meningiomas. The possible use of the GFA protein as a marker for astroglial neoplasia is discussed.
Five foetal antigens were found in foetal brain, but none in the tumours. a-Foetoprotein could only be demonstrated in foetal tissue extracts, including foetal brain, but not in tumours. Ferritin was detected in all tumour extracts, although the amounts determined were unrelated to histological tumour type.
IN recent years, experiments have been carried out to evaluate the immune response to brain tumours in braintumour patients (Levy, Mahalay and Day, 1972; Oda, 1974) , but few immunochemical investigations have been published on the antigenic composition of human brain tumours (Winters and Rich, 1975) . The present study was undertaken to describe the antigenic composition of the two most common intracranial tumours (glioblastomas and meningiomas) by use of quantitative immunoelectrophoretic methods (Axelsen, Kr0ll and Weeke, 1973) .
The presence or absence of neo-antigens associated with the neoplastic transformation was tested with different antisera raised in rabbits by injection~s of extracts of glioblastomas and meningiomas. The different tissue extracts were further analysed, using antibodies against foetal brain.
Analysis of two brain-specific antigens was performed. The glial fibrillary acidic protein (GFA) Sweden. Polyspecific rabbit antisera were raised against extracts of glioblastomas, meningiomas and foetal brain (12-16th week of gestation). Four rabbits were immunized with glioblastoma extracts for 1 year. Three different tumours of identical histology were used to prepare antigens and after bleeding the antisera were pooled. Three rabbits were immunized with meningioma extracts originating from 2 tumours. Immunization with foetal brain was performed on 5 rabbits for more than 1 year, using extracts of 3 foetal brains sequentially. The immunization protocol and the immunoglobulin purification method were those of Harboe and Ingild (1973) .
An antiserum specific for human ferritin was a gift from Dr B. G. Johansson, Lund, Sweden.
Absorption of antisera was performed by antigens covalently linked to Sepharose using CNBr-activated Sepharose ® purchased from Pharmacia, Uppsala, Sweden. One hundred and fifty milligrammes protein was coupled to 15 g Sepharose. To this, aliquots of 100 ml antiserum were absorbed, and the absorbed antibodies were eluted by 2 M guanidinium HC1, pH 3 0, before another application of antiserum. The efficiency of the absorptions was tested by crossed IE of the antigen preparations used for absorptions against the absorbed antisera.
An antiserum specific for human cxfoetoprotein was purchased from DAKO Immunoglobulins A/S, Copenhagen, Denmark.
Quantitative immunoelectrophoresis (QIE). -QIE (crossed IE, crossed-line IE and rocket IE) was performed as described in the manual by Axelsen, Kr0ll and Weeke (1973) .
The agarose gels contained 022% Triton X-100, in order to keep detergent-solubilized membrane proteins in solution. GFA, S-100 and ferritin were estimated by rocket IE, and expressed relative to total protein as per cent of the content in an extract of whole normal adult brain.
RESULTS
Samples from 20 tumour patients and from 2 non-tumour patients were examined. A small slice of each sample was put into formalin at the time of extraction. The microscopic examination of this slice was taken as representative of the sample, and was compared with the tissue sample originally examined by the neuropathologist. Of 11 samples from operations for glioblastomas, 7 slices were well preserved, 3 showed marked necrosis, and one contained only white and grey matter with gliosis, but no tumour tissue. Two samples from non-tumour operations showing a well preserved gliosis were included in the study. Three tumours were carcinomatous metastases to the brain, all showing histological signs of contamination with adjacent brain. Six meningiomas were examined. In this way 5 categories were examined: 7 glioblastomas, 3 necrotic glioblastomas, 3 samples of gliosis, 3 metastases and 6 meningiomas. No suitable astrocytoma lower than Grade IV was found during the study. No tumour of disputable histology was included in the series. Fig. 1 shows a crossed IE of foetal brain extract against unabsorbed polyspecific foetal brain antibodies. It was shown by crossed-line IE experiments that the foetal brain contained 5 foetal antigens (dots in Fig. 1 ). After sequential absorptions of the antiserum with insolubilized serum, haemolysate and adult brain, antibodies against these antigens were still present. In extracts of adult brain, adult blood, foetal liver and foetal blood, these antigens were not present. Crossed-line IE used for this purpose is able to detect foetal antigens present in tissue extracts in amounts higher than 1-5% of the amount present in the reference tissue (foetal brain). oc-Foetoprotein in Fig. 1 average in glioblastomas, but decreased in necrotic samples. S-100 was found in rather low amounts except in gliosis.
Ferritin was detected in all extracts, although the amounts determined were unrelated to sample type. Analytical standard deviation of the analyses of these 3 proteins by QIE was found to be 10%. GFA and S-100 in the glioblastomas were immunochemically identical to the normal adult GFA and S-100. GFA and S-100 were also present in foetal brain extract. Foetal S-100 was immunochemically identical to the adult protein.
However, foetal GFA precipitates in a reproducibly different manner than adult GFA, indicating a physico-chemical difference (Fig. 5) .
A.U. GFA in both extracts shows reaction of immunochemical identity; however the foetal GFA precipitate is more blurred than the adult GFA precipitate, indicating physico-chemical differences.
ax-Foetoprotein was not present in the tumours, but only in foetal brain extract, probably due to contamination with foetal blood.
DISCUSSION
In spite of extensive experimental work with polyspecific antisera, and the sensitive and highly resolving QIE methods, we were unable to find any brain-tumour-associated antigen or any onco-foetal brain antigen in human glioblastomas or meningiomas. This is consistent with the reports of Hass (1966) and Delpech et al. (1972) where the glioblastomas are concerned, but inconsistent with the meningioma study by Winters and Rich (1975) and the studies by Trouillas on glioblastomas (1971 Trouillas on glioblastomas ( , 1972 , and other studies (Mahalay, Mahalay and Day, 1965; Lim and Kluskens, 1972; Wahlstrom et al., 1974) . In the present study, 5 foetal antigens were found in foetal brain, but none of these were found in the tumours. Our results therefore do not confirm Trouillas' reports (Trouillas, 1971 (Trouillas, , 1972 on the existence of a human carcino-foetal glial antigen. The reason for the above-mentioned discrepancies is probably that different techniques have been used: Trouillas (1971 Trouillas ( , 1972 used patients' antibodies after autochthonous immunization instead of rabbit antibodies.
In the present study rabbit antisera against glioblastoma extracts and meningioma extracts revealed antigens which were apparently tumour-associated, since they were not identical to any antigen found in normal or in foetal brain. However, they were present in extract from normal adult liver, indicating that the antigens were normal tissue components.
Few reports have considered the immunochemical composition of meningiomas (Winters and Rich, 1975) . The results of our study do not confirm the findings of meningioma-associated antigens, but our extraction procedure was different from that of Winters and Rich, and therefore the findings are not directly comparable.
Also, cellular immune reactions have indicated the existence of human tumourassociated antigens (Brooks et al., 1972; Levy et al., 1972; Kumar et al., 1973; Oda, 1974) . In these studies the chemical nature of the antigens was not investigated, but they are usually presumed to be membrane proteins. With the methods used in the present study it has been possible in normal brain extracts to estimate membrane-bound brain antigens (Bock et at., 1975) and therefore the conclusions of the present study also apply to membrane antigens.
The presence of the S-100 antigen in intracranial tumours has been investigated before, and used in the discussion of the histogenesis of different tumour types (Pfeiffer et al., 1972) . Haglid et al. (1973) found a content of S-100 in lowgrade astrocytomas that equalled the content in normal white matter; but in glioblastomas they found a significantly lower level, which is in accordance with our data. The difference in the content of S-100 in little or highly differentiated astrocytomas reported by Haglid et al. (1973) has been used for discussion of the histopathological concept of dedifferentiation, although it seems difficult to assess the degree of maturation of a certain cell type, only from knowledge of one protein the function of which is still unclear. Furthermore, the problems of relating the amount of a specific protein to the total volume occupied by the cell type to which the protein is assumed to be restricted have not at all been solved. These problems comprise the heterogeneity of the brain cells, the differences in water content, especially in pathological cases, and the abundance of stromal elements in the tumours.
The presence of the GFA protein in astrocytomas has previously been demonstrated by Uyeda, Eng and Bigami (1972) by means of immunofluorescence microscopy, but results of estimation of GFA in human tumours have not been published before. The average enrichment of GFA in glioblastomas was, in the present study, found to be 2 6 times that in normal whole brain. This is, however, a high estimate, due to our standard being expressed relative to total protein of a whole brain extract, and the tumours do not represent grey matter, in which the GFA is present in lower concentration than in white matter. It seems justifiable to say, from the present study, especially when one compares meningiomas with glioblastomas ( Fig. 2) , that the glioblastomas have retained some of the biochemical specificity of cells derived from the neural tube. It is not possible to state whether the content of GFA in the metastases reflects a potentiality in the neoplastic cells for synthesis of this protein, or whether it is a measure of contamination from adjacent brain. It is of interest that the S-100 and GFA found in glioblastomas were immunochemically identical to the proteins of normal adult brain, although GFA in foetal brain extracts differed slightly with regard to precipitate morphology from adult brain extracts (cf. Fig. 5 ).
Besides the increased content of GFA in tumours shown in the present study, an increased amount of GFA has been found in glial multiple sclerosis scars, from which GFA was originally isolated (Eng et at., 1971) , in injured brain tissue (Bignami and Dahl, 1974) , and in short-term cultivated glial cells (Bock et al., 1975) . As GFA is considered an astrocytic protein 
